FDA clears Bioness Medical’s neuromodulation system for stroke rehabilitation
Bioness Medical’s oral neuromodulation system for rehabilitating stroke patients with gait deficits has secured clearance from the US Food and…
All articles by Ross Law
Ross Law
Ross Henry Law is a reporter for Medical Device Network. His key interest areas in healthcare include regulation, mental health, neurology, oncology, and Alzheimer's disease. Ross also has extensive prior experience in covering the captive insurance, retail, and technology sectors.
-
-
GE HealthCare introduces upgrade pathways for interventional suite modernisation
GE HealthCare is introducing Allia upgrade pathways to facilitate a modernisation of older interventional environments, along with extending the lifetime…
-
Podcast: Why vascular care in England needs reformation
On 17 March, the Vascular and Venous Disease All-Party Parliamentary Group (VVAPPG) launched a whitepaper setting out a roadmap for…
-
ZEISS and Envision Health strike VR partnership to advance glaucoma care
ZEISS Medical Technology and Envision Health Technology are joining forces to advance glaucoma care with gamified virtual reality (VR). The…
-
Abiomed’s Impella heart pump introducer kits linked to leakage issue in FDA alert
The US Food and Drug Administration (FDA) has issued an early alert over a ‘potentially high-risk’ leakage issue associated with…
-
FiberSense plans CGM’s commercial readiness following CE mark
FiberSense has obtained a CE mark for its continuous glucose monitoring (CGM) system, setting the stage for the medical device’s…
-
Podcast: What the AHA-ASA’s updated guidelines mean for acute ischemic stroke care
In January 2026, the American Heart and American Stroke Association (AHA/ASA) issued new care guidelines for acute ischemic stroke (AIS)…
-
Sonire Therapeutics awarded $13m from Japanese government-backed innovation agency
The government of Japan has inducted Sonire Therapeutics’ Japan-based group into an innovation programme, along with equipping the company with…
-
Italy’s WISE raises $34.8m in Series D to advance spinal cord stimulator development
WISE has raised €30m ($34.8m) to advance the development of its spinal cord stimulation (SCS) device for chronic pain treatment.…
-
NHS Confed 2026: what drives successful AI implementation in the NHS?
The UK’s Labour government has ambitious plans to transform the country’s National Health Service (NHS) into one that is more…